Riding high after its IPO, Moderna chief nabs $59M, biopharma's biggest 2018 paycheck

It’s not often that biotech sees a record-breaking IPO, but longtime unicorn and fundraising champ Moderna managed just that last year. And the newly public company’s CEO topped the charts himself with a 2018 compensation package bigger than any other biopharma chief’s pay.